港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

藥捷安康-B

140.800

-2.400-1.68%

成交量：71.81萬

成交額：1.02億

市值：558.98億

市盈率：-179.20

高：145.900

開：143.300

低：137.000

收：143.200

52周最高：679.500

52周最低：20.200

股本：3.97億

香港流通股本：3.02億

量比：0.25

換手率：0.24%

股息：- -

股息率：- -

每股收益(LYR):-0.786

淨資產收益率：-39.08%

總資產收益率：-21.10%

市淨率：87.93

市盈率(LYR):-179.20

市銷率: - -

資料載入中...

總覽公司新聞公告

從百億到千億，藥捷安康發生了什麼？

藥捷安康股價坐上過山車「妖股」背後業績成色幾何？

藥捷安康-B09月24日主力淨流出70.1萬元散户資金買入

藥捷安康-B盤中強勢拉昇漲超18%！該股上市至今累漲逾1200%

老虎资讯综合

醫藥生物行業專題研究：創新藥產業趨勢已成進軍全球商業化

坐上港股過山車，藥捷安康的意外還會重演嗎？

覆盤藥捷安康-B事件始末...

藥捷安康-B09月22日遭主力拋售58.0萬元

千億市值背後：一家「三無」Biotech的資本狂飆與泡沫隱憂

一週港股牛熊榜 | 機器人概念股掀漲勢，德昌電機本週飆升40%；山高控股暴跌80%，港證監曾點名股權高度集中

老虎资讯综合

藥捷安康-B：2025中期報告

香港交易所

藥捷安康-B09月19日遭主力拋售750.6萬元

「妖股」熄火，藥捷安康尾盤跌幅擴大至18%

老虎资讯综合

港股異動 | 藥捷安康-B(02617)尾盤跌近18% 較週二高點已跌超77% 總市值已不足600億港元

藥捷安康-B持續走低，日內跌幅擴大至16.5%

每日经济新闻

暴漲1293%能穩住嗎？藥捷安康「閃崩」後又跌了

阿尔法工场

18A，暴富製造機

北京商报官方账号

藥捷安康背後的資本惡局

坐上港股過山車，藥捷安康的意外還會重演嗎？

半年營收為0！這家藥企股價單日暴跌53.73%透露哪些危機？

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02617/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"藥捷安康-B","latestPrice":140.8,"timestamp":1759133289390,"preClose":143.2,"halted":0,"volume":718122,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7857250640433961,"marketStatus":"未開盤","change":-2.4,"latestTime":"09-29 16:08:09","open":143.3,"high":145.9,"low":137,"amount":101534190,"amplitude":0.062151,"askPrice":140.9,"askSize":3500,"bidPrice":140.8,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.677840132841989,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1759195800000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":143.2,"openAndCloseTimeList":[[1759109400000,1759118400000],[1759122000000,1759132800000]],"volumeRatio":0.250171,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.785725,"volumeRatio":0.250171,"shares":397000000,"dividePrice":0,"high":145.9,"amplitude":0.062151,"preClose":143.2,"low":137,"week52Low":20.2,"pbRate":"87.93","week52High":679.5,"institutionHeld":0,"latestPrice":140.8,"committee":-0.272727,"eps":-0.7857250640433961,"divideRate":0,"volume":718122,"delay":0,"ttmEps":-0.677840132841989,"open":143.3,"prevYearClose":13.15,"prevWeekClose":143.2,"prevMonthClose":54.15,"prevQuarterClose":30.15,"fiveDayClose":147.7,"twentyDayClose":58,"sixtyDayClose":32.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-09-26","current":-207.729231,"percent":0.057971,"low":-380.446233,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"high":-17.403134,"avg":-77.538728,"sd":65.208791,"marketCap":56835741045},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045}],"updateTime":1759169837949},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2570054906","title":"從百億到千億，藥捷安康發生了什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2570054906","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570054906?lang=zh_tw&edition=fundamental","pubTime":"2025-09-25 12:13","pubTimestamp":1758773629,"startTime":"0","endTime":"0","summary":"文｜《投资者网》蔡俊9月，药捷安康成了创新药“显眼包”。同时，公司与LG Chem共同宣布VAP-1抑制剂在美国成功实现首例受试者给药。千亿市值的是与非从默默无闻到人尽皆知，药捷安康只用了三个月。这种大开大合的剧情，公司发布公告表示，不知悉异常变动的任何原因，集团营运维持正常，财务状况无重大变动。截至目前，公司96.2%的股份由上市前投资者锁定，IPO发行股份占总股本的3.8%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1758765218687809540","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"2570734051","title":"藥捷安康股價坐上過山車 「妖股」背後業績成色幾何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2570734051","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570734051?lang=zh_tw&edition=fundamental","pubTime":"2025-09-25 11:38","pubTimestamp":1758771503,"startTime":"0","endTime":"0","summary":"从消息面来看，药捷安康此轮股价的抬升与公司核心产品的临床进展相关。扣除基石投资者认购部分及原股东持股后，药捷安康在二级市场上的实际可自由交易的流通股仅约549万股。截至2025年6月30日，药捷安康账上现金及现金等价物同比减少21%至4.49亿元。当前药捷安康的市值已经回落至590亿港元，相较于高峰期的市值下跌近八成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925114347a69ca5be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925114347a69ca5be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"2569774540","title":"藥捷安康-B09月24日主力淨流出70.1萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2569774540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569774540?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 16:15","pubTimestamp":1758701731,"startTime":"0","endTime":"0","summary":"09月24日, 药捷安康-B股价跌1.57%，报收162.50元，成交金额4.1亿元，换手率0.80%，振幅12.72%，量比0.35。药捷安康-B今日主力资金净流出70.1万元，上一交易日主力净流入277.7万元。该股近5个交易日下跌22.28%，主力资金累计净流出1793.5万元；近20日主力资金累计净流出1438.8万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092417094095421347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092417094095421347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1176140056","title":"藥捷安康-B盤中強勢拉昇漲超18%！該股上市至今累漲逾1200%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176140056","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176140056?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 09:57","pubTimestamp":1758592660,"startTime":"0","endTime":"0","summary":"9月23日，$药捷安康-B(02617)$盘中强势拉升，现涨超18%！该股上市至今累涨逾1200%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9f571b022481e7a7a299180f01a8da28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4614","02617"],"gpt_icon":0},{"id":"2569951627","title":"醫藥生物行業專題研究：創新藥產業趨勢已成 進軍全球商業化","url":"https://stock-news.laohu8.com/highlight/detail?id=2569951627","media":"天风证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569951627?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 00:00","pubTimestamp":1758556800,"startTime":"0","endTime":"0","summary":"中国已成为全球靶点验证到IND路径中效率最高的国家之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923170635953fc337&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923170635953fc337&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","02616","01801","06160","BK1161","06978","BK1574","02617"],"gpt_icon":1},{"id":"2569394637","title":"坐上港股過山車，藥捷安康的意外還會重演嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2569394637","media":"药闻社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569394637?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 22:56","pubTimestamp":1758553007,"startTime":"0","endTime":"0","summary":"在2025年下半年这波港股创新药的强势回暖行情中，一家名为药捷安康的公司，在股价火箭式飞升后用迅速掉落。股价波动剧烈的直接原因，在于国证港股通创新药指数实施季度定期调整，并将药捷安康纳入进去，大批被动资金卷入。在这一系列的推动下，药捷安康的股价正式起飞。9月16日，药捷安康在盘中创下679.5港元的历史高点，市值接近2700亿港元。因此，造成市值蒸发悲剧的，不仅有过小的流通盘，还有药捷安康过早的上市时间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923000335a43cc7ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923000335a43cc7ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","HSCEI","HSTECH","BK1161"],"gpt_icon":1},{"id":"2569200975","title":"覆盤藥捷安康-B事件始末...","url":"https://stock-news.laohu8.com/highlight/detail?id=2569200975","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569200975?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 16:47","pubTimestamp":1758530836,"startTime":"0","endTime":"0","summary":"截至最新，跟踪国证港股通创新药指数的4只ETF，药捷安康的权重已被显著调低，远低于其在指数中2.6%的理论权重。目前，相关ETF已通过主动操作大幅降低了药捷安康的持仓乃至清仓，净值波动与药捷安康股价的关联性已显著减弱。此事件预计将推动市场对指数编制规则，比如新股纳入条件、流动性考量、ETF成分股流动性监测以及信息披露透明度的进一步反思和完善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922165144a43c0067&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922165144a43c0067&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2569202038","title":"藥捷安康-B09月22日遭主力拋售58.0萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569202038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569202038?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 16:16","pubTimestamp":1758528964,"startTime":"0","endTime":"0","summary":"09月22日, 药捷安康-B股价跌1.47%，报收147.70元，成交金额5.3亿元，换手率1.17%，振幅13.94%，量比0.34。药捷安康-B今日主力资金净流出58.0万元，连续4日净流出，上一交易日主力净流出750.6万元。该股近5个交易日下跌64.43%，主力资金累计净流出3791.6万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1646.4万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922162413953d65d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922162413953d65d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2569727316","title":"千億市值背後：一家「三無」Biotech的資本狂飆與泡沫隱憂","url":"https://stock-news.laohu8.com/highlight/detail?id=2569727316","media":"药事纵横","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569727316?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 06:02","pubTimestamp":1758492142,"startTime":"0","endTime":"0","summary":"2025年上半年，药捷安康收入为零，期内亏损1.23亿元。截至2025年6月23日上市，公司总股本3.97亿股，其中H股3.02亿股。风险警示衡量一家Biotech公司的估值，市研率是一个关键指标。而行业平均水平，根据对多家已上市Biotech企业的统计，市研率约为12倍。回顾历史，不乏Biotech企业因估值泡沫破裂而市值大幅缩水的案例。再看2024年美股市场，Aditxt、CNS Pharmaceuticals等Biotech公司股价跌幅均超过99%。结语药捷安康的千亿市值，既是一场资本的狂欢，也是一面行业的镜子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922060551a72ddc0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250922060551a72ddc0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"1184699731","title":"一週港股牛熊榜 | 機器人概念股掀漲勢，德昌電機本週飆升40%；山高控股暴跌80%，港證監曾點名股權高度集中","url":"https://stock-news.laohu8.com/highlight/detail?id=1184699731","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184699731?lang=zh_tw&edition=fundamental","pubTime":"2025-09-20 09:20","pubTimestamp":1758331230,"startTime":"0","endTime":"0","summary":"自2025年9月17日至2025年11月15日面向社会公众征求意见，这意味着L2智驾新标准距离正式发布又近一步。该机构指，新标准对智驾系统安全性提出更多要求，规范DMS驾驶员监控系统，预计L2智驾准入难度或将大幅提升。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"03b5cf1bcd1337275a088b73818f952b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","HSI","06088","09969","00412","06869","00020","09678","09866","02617","00179"],"gpt_icon":1},{"id":"2568266461","title":"藥捷安康-B：2025中期報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2568266461","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568266461?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 16:42","pubTimestamp":1758271342,"startTime":"0","endTime":"0","summary":"公司核心产品替恩戈替尼正在中国进行胆管癌适应症的注册性II期临床试验，预计于2025年下半年完成；同时在美国等地区进行国际多中心III期临床试验。药捷安康于2025年上半年录得亏损1.23亿元人民币，较去年同期亏损1.60亿元收窄23.4%。公司于2025年6月23日在港交所主板上市，全球发售募集资金净额约1.61亿港元，主要用于替恩戈替尼的多区域注册III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919213202a72a647e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919213202a72a647e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2568253748","title":"藥捷安康-B09月19日遭主力拋售750.6萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568253748","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568253748?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 16:15","pubTimestamp":1758269738,"startTime":"0","endTime":"0","summary":"09月19日, 药捷安康-B股价跌18.18%，报收149.90元，成交金额6.4亿元，换手率1.25%，振幅21.94%，量比0.30。药捷安康-B今日主力资金净流出750.6万元，连续3日净流出，上一交易日主力净流出1192.6万元。该股近5个交易日下跌22.60%，主力资金累计净流出863.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1588.5万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919161937a436b83c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919161937a436b83c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"1156145458","title":"「妖股」熄火，藥捷安康尾盤跌幅擴大至18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156145458","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156145458?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 15:51","pubTimestamp":1758268302,"startTime":"0","endTime":"0","summary":"此前一度飙升50倍。","market":"hk","thumbnail":"https://static.tigerbbs.com/bbe0dc929d5aac050fe7d1c2e15a7fa7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bbe0dc929d5aac050fe7d1c2e15a7fa7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2568580292","title":"港股異動 | 藥捷安康-B(02617)尾盤跌近18% 較週二高點已跌超77% 總市值已不足600億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568580292","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568580292?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 15:45","pubTimestamp":1758267940,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药捷安康-B尾盘跌近18%，低见150.2港元，较周二盘中高点679.5港元已跌超77%。公开资料显示，药捷安康今年6月23日在港交所上市，发行价为13.15港元，总股本约3.97亿股，上市时总市值约52亿港元。9月15日，药捷安康被纳入“国证港股通创新药指数”。市场人士指出，药捷安康在指数中的初始权重约为2.63%，据推算相关指数基金需被动配置至少超过6亿港元的该股票，由此触发股价剧烈波动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161","HSCEI","YANG","BK4614"],"gpt_icon":0},{"id":"2568584872","title":"藥捷安康-B持續走低，日內跌幅擴大至16.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568584872","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568584872?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 15:40","pubTimestamp":1758267630,"startTime":"0","endTime":"0","summary":"每经AI快讯，9月19日，药捷安康-B(02617.HK)持续走低，日内跌幅扩大至16.5%，报152.9港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509193518428293.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"de0c57402920c029a2335a8a6d9d3d7a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509193518428293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2568727282","title":"暴漲1293%能穩住嗎？藥捷安康「閃崩」後又跌了","url":"https://stock-news.laohu8.com/highlight/detail?id=2568727282","media":"阿尔法工场","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568727282?lang=zh_tw&edition=fundamental","pubTime":"2025-09-19 08:09","pubTimestamp":1758240559,"startTime":"0","endTime":"0","summary":"药捷安康“闪崩”后又跌了）图源：图虫创意导语：药捷安康上市不到3个月已经上涨1293.16%，但9月16日股价暴跌也让市场提起警惕之心。9月15日，药捷安康单日股价涨幅高达115.58%。药捷安康还在公告中表示，临床前实验结果表明，替恩戈替尼与氟维司群的联合用药针对内分泌治疗耐药的乳腺癌细胞具有药理学协同作用。创新性的疗法和临床试验的新进展，被视作药捷安康核心产品的重要突破。而同期，药捷安康账上现金及现金等价物为4.49亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919082506979c0846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919082506979c0846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2568766405","title":"18A，暴富製造機","url":"https://stock-news.laohu8.com/highlight/detail?id=2568766405","media":"北京商报官方账号","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568766405?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 22:25","pubTimestamp":1758205507,"startTime":"0","endTime":"0","summary":"9月15日，王星星决定出手一试。一家18A企业相关人士如是说。暴富故事频繁上演随着港股创新药市场整体回暖，今年以来，药捷安康所在的18A已创造了不少“暴富神话”。据了解，2018年4月，港交所推行上市制度改革，新增第18A章《生物科技公司》，允许未有收入、未有利润的生物科技公司赴港上市。在这七年中，18A板块市场情绪几经起伏，不仅缔造了不少财富神话，也经历过行业低谷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918222818a4cdeae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918222818a4cdeae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","02617","HSCEI","BK1574","06978","09606","BK1161"],"gpt_icon":1},{"id":"2568740444","title":"藥捷安康背後的資本惡局","url":"https://stock-news.laohu8.com/highlight/detail?id=2568740444","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568740444?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 20:02","pubTimestamp":1758196920,"startTime":"0","endTime":"0","summary":"　　公司叫做药捷安康，你们一定要记住这个名字，这是真正的金融巨盗的玩法。药捷安康在IPO前共完成9轮融资，累计融资金额达17.23亿元人民币，投资方包括先进制造基金、国投大湾区基金、金浦健康基金、CPE源峰等二十多家机构。　　9月12日上涨77.09%，9月15日大涨115.58%，9月16日盘中，药捷安康一度大涨63%，最高每股报679.5港元，市值逼近2700亿港元。　　根据相关ETF申赎清单，药捷安康在这个指数的权重约为2.62%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2025-09-18/doc-infqxmri0579721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02617"],"gpt_icon":1},{"id":"2568474185","title":"坐上港股過山車，藥捷安康的意外還會重演嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2568474185","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568474185?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 19:40","pubTimestamp":1758195610,"startTime":"0","endTime":"0","summary":"股价波动剧烈的直接原因，在于国证港股通创新药指数实施季度定期调整，并将药捷安康纳入进去，大批被动资金卷入。而药捷安康真正可自由流通的股份约549万股，仅占总股本的1.38%，从而导致股价被迅速推高。在这一系列的推动下，药捷安康的股价正式起飞。9月16日，药捷安康在盘中创下679.5港元的历史高点，市值接近2700亿港元。因此，造成市值蒸发悲剧的，不仅有过小的流通盘，还有药捷安康过早的上市时间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918194556953667db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918194556953667db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","02617","BK1161","HSCEI"],"gpt_icon":1},{"id":"2568476553","title":"半年營收為0！這家藥企股價單日暴跌53.73%透露哪些危機？","url":"https://stock-news.laohu8.com/highlight/detail?id=2568476553","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568476553?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 18:32","pubTimestamp":1758191579,"startTime":"0","endTime":"0","summary":"9月16日开盘，药捷安康延续涨势，盘中股价大涨63%，最高点每股报679.5港元。但当日午后该股大幅跳水，终收于192港元/股，下跌53.73%。针对几日股价持续波动，药捷安康发布公告称，董事会确认集团的业务营运维持正常，且集团的业务营运及财务状况并无重大变动。董事会不知悉股价及成交量异常变动的任何原因。2025年上半年，公司营业收入为0，仅有一些来自于银行利息收入和政府补助的其他收入，税前继续亏损1.23亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918183335953646b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918183335953646b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","02617","01801","BK1500","LU0307460666.USD","LU1251922891.USD","LU1770034418.SGD","BK1588","LU1969619763.USD","LU1719994722.HKD","LU2328871848.SGD","BK1583","HSTECH","LU1303224171.USD","01276","06160","LU0588546209.SGD","BK1161"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":155,"code":"91000000","status":"200"}]}}